Genmab: files offer for ADS, Nasdaq listing
(CercleFinance.com) - Genmab on Tuesday filed a proposed public offering of American Depositary Shares (ADSs) with US regulators, applying for listing on the Nasdaq, the company said.
The Danish biotech firm said in a registration statement with the US Securities and Exchange Commission that its board of directors has not yet finally decided whether to proceed with the listing and offering, or its timing.
Genmab - which is currently listed on Nasdaq Copenhagen - said each of its ADS would represent one-tenth of one ordinary share.
Copyright (c) 2019 CercleFinance.com. All rights reserved.